MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells

References

• MutoMNakaneMKatadaCSquamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sitesCancer200410161375138115368325
   PubMed Web of Science ®Google Scholar
• AzadAKBairatiISamsonEValidation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survivalClin Cancer Res201218119620622076708
   PubMed Web of Science ®Google Scholar
• ChiangKCChenTCThe anti-cancer actions of vitamin DAnticancer Agents Med Chem201313112613923094926
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNChenMFChenTCHepatocellular carcinoma and vitamin D: a reviewJ Gastroenterol Hepatol201126111597160321880026
   PubMed Web of Science ®Google Scholar
• GedlickaCHagerGWeissenbockM1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neckJ Oral Pathol Med200635847247816918598
   PubMed Web of Science ®Google Scholar
• HagerGFormanekMGedlickaCThurnherDKnererBKornfehlJ1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neckActa Otolaryngol2001121110310911270487
   PubMed Web of Science ®Google Scholar
• PrudencioJAkutsuNBenlimameNAction of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinomaJ Natl Cancer Inst2001931074575311353784
   PubMed Web of Science ®Google Scholar
• OnoKYoshidaASaitoNEfficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cellsJ Org Chem200368197407741512968893
   PubMed Web of Science ®Google Scholar
• HouraiSFujishimaTKittakaAProbing a water channel near the A-ring of receptor-bound 1 alpha,25-dihydroxyvitamin D3 with selected 2 alpha-substituted analoguesJ Med Chem200649175199520516913708
   PubMed Web of Science ®Google Scholar
• SuharaYNiheiKIKuriharaMEfficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptorsJ Org Chem200166268760877111749604
   PubMed Web of Science ®Google Scholar
• YasudaKIkushiroSKamakuraMHuman cytochrome P450-dependent differential metabolism among three 2alpha-substituted-1alpha,25-dihydroxyvitamin D(3) analogsJ Steroid Biochem Mol Biol2013133849222982757
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNChenHY19-Nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cellsSteroids201176131513151921888924
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNChenSCMART-10, a new generation of vitamin D analog, is more potent than 1alpha,25-dihydroxyvitamin D(3) in inhibiting cell proliferation and inducing apoptosis in ER+MCF-7 breast cancer cellsEvid Based Complement Alternat Med2012201231087223304196
   PubMed Web of Science ®Google Scholar
• KittakaAYoshidaAChiangKCPotent 19-norvitamin D analogs for prostate and liver cancer therapyFuture Med Chem20124162049206523157238
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNHsuJTEvaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivoCell Cycle20131281316132523549173
   PubMed Web of Science ®Google Scholar
• ChiangKCChenSCYehCNMART-10, a less calcemic vitamin D analog, is more potent than 1alpha,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitroJ Steroid Biochem Mol Biol2014139546024125734
   PubMed Web of Science ®Google Scholar
• ChiangKCKuoSFChenCHMART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potentialCancer Lett20153691768526282787
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNHsuJTThe vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial–mesenchymal transition in pancreatic cancer cellsCancer Lett2014354223524425149065
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNHsuJTMART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomeraseJ Steroid Biochem Mol Biol201313842743424044969
   PubMed Web of Science ®Google Scholar
• FlanaganJNZhengSChiangKCEvaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancerAnticancer Res20092993547355319667147
   PubMed Web of Science ®Google Scholar
• Iglesias-GatoDZhengSFlanaganJNSubstitution at carbon 2 of 19-nor-1alpha,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cellsJ Steroid Biochem Mol Biol20111273–526927521911059
   PubMed Web of Science ®Google Scholar
• YilmazMChristoforiGMechanisms of motility in metastasizing cellsMol Cancer Res20108562964220460404
   PubMed Web of Science ®Google Scholar
• LamouilleSXuJDerynckRMolecular mechanisms of epithelial–mesenchymal transitionNat Rev Mol Cell Biol201415317819624556840
   PubMed Web of Science ®Google Scholar
• ThieryJPAcloqueHHuangRYNietoMAEpithelial–mesenchymal transitions in development and diseaseCell2009139587189019945376
   PubMed Web of Science ®Google Scholar
• HollierBGEvansKManiSAThe epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapiesJ Mammary Gland Biol Neoplasia2009141294319242781
   PubMed Web of Science ®Google Scholar
• ArumugamTRamachandranVFournierKFEpithelial to mesenchymal transition contributes to drug resistance in pancreatic cancerCancer Res200969145820582819584296
   PubMed Web of Science ®Google Scholar
• KurreyNKJalgaonkarSPJoglekarAVSnail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cellsStem Cells20092792059206819544473
   PubMed Web of Science ®Google Scholar
• PeinadoHOlmedaDCanoASnail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nat Rev Cancer20077641542817508028
   PubMed Web of Science ®Google Scholar
• KimJBIslamSKimYJN-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motilityJ Cell Biol200015161193120611121435
   PubMed Web of Science ®Google Scholar
• BirchmeierWHulskenJBehrensJAdherens junction proteins in tumour progressionCancer Surv1995241291407553658
   PubMedGoogle Scholar
• TsanouEPeschosDBatistatouACharalabopoulosACharalabopoulosKThe E-cadherin adhesion molecule and colorectal cancer. A global literature approachAnticancer Res2008286A3815382619189669
   PubMed Web of Science ®Google Scholar
• JooYERewJSParkCSKimSJExpression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinomaPancreatology20022212913712123093
   PubMed Web of Science ®Google Scholar
• DeryckeLDBrackeMEN-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signallingInt J Dev Biol2004485–646347615349821
   PubMed Web of Science ®Google Scholar
• NakajimaSDoiRToyodaEN-cadherin expression and epithelial–mesenchymal transition in pancreatic carcinomaClin Cancer Res20041012 Pt 14125413315217949
   PubMed Web of Science ®Google Scholar
• LotfiAMohammadiGSanieeLMousaviagdasMChavoshiHTavassoliASerum level of matrix metalloproteinase-2 and -9 in patients with laryngeal squamous cell carcinoma and clinical significanceAsian Pac J Cancer Prev201516156749675126434905
   PubMedGoogle Scholar
• TimmsPMMannanNHitmanGACirculating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?QJM2002951278779612454321
   PubMed Web of Science ®Google Scholar